Actinium Pharmaceuticals (ATNM) EPS (Diluted) (2013 - 2026)
Actinium Pharmaceuticals (ATNM) EPS (Diluted) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.15 |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - | 0.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.89 |
| Mar 31, 2026 | -0.18 |
| Dec 31, 2025 | -0.20 |
| Sep 30, 2025 | -0.20 |
| Jun 30, 2025 | -0.22 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.72 |
| Mar 31, 2024 | -0.76 |
| Dec 31, 2023 | -0.36 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.58 |
| Mar 31, 2023 | -0.46 |
| Dec 31, 2022 | -0.47 |
| Sep 30, 2022 | -0.60 |
| Jun 30, 2022 | -0.33 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | -0.39 |
| Sep 30, 2021 | -0.30 |